Bellevue Group Ag Astrazeneca PLC Transaction History
Bellevue Group Ag
- $5.02 Billion
- Q4 2024
A detailed history of Bellevue Group Ag transactions in Astrazeneca PLC stock. As of the latest transaction made, Bellevue Group Ag holds 35,700 shares of AZN stock, worth $2.68 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
35,700
Previous 33,500
6.57%
Holding current value
$2.68 Million
Previous $2.61 Million
10.38%
% of portfolio
0.05%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.52 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.78 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...